These 'Goldilocks' tech stocks are defensive plays during coronavirus, but could thrive after too

has outperformed in 2020 as tech stocks have proven resilient during the pandemic, but investors could have beaten the index and popular sector ETFs by focusing on smaller slices of the industry, according to research from PivotalPath.

The firm, which works with investors and money managers to provide information about hedge funds, put together baskets for its clients to see what areas were driving the outperformance in tech.

Pro Your missing what a shame!

Pro Market movers.... $MRNA at $81.70 $NVAX at $110 Looks like Moderna is ahead at coming Phase 3 CORONAVIRUS COVID19 VACCINE trial on July 27, 2020 ... watchkut folks ... $MRNA moves the STOCKMARKET THIS WEEK

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

European stocks head for higher open on vaccine hopesEuropean stocks are expected to open higher Wednesday as investor hopes for a coronavirus vaccine rise. Oh so it’s a “COVID hopes” day as opposed to a “fears” day very useful info They throw these fear news on days they buy and then once they are locked and loaded they release the good news
Source: CNBC - 🏆 12. / 72 Read more »